Skip to content

to study the effect of Metocloparamide and Dexamethsone drugs in reducing vomiting in patients undergoing laproscopic cholecystectomy

role of low dose metocloparamide and dexamethasone combination in prevention of nausea and vomiting in laproscopic cholecystectomy patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/05/002668
Enrollment
90
Registered
2012-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients of ASA grade I&II planned for laproscopic cholycestectomy patients age of 18-55yr patients weight between 30-75kg

Interventions

Intervention1: Dexamethasone Metocloparamide normal saline : Group A- Metocloparamide 10 mg i.v plus Dexamethasone 5mg i.v Group B- Metocloparamide 10 mg i.v plus Dexamethasone 2.5mg i.v Group C- Me

Sponsors

Subharti Medical College Meerut
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: pt. of ASA grade I & II , weight between 30 to 75kg

Exclusion criteria

Exclusion criteria: Pt ASA grade 3 & 4 Pt who have received opoids ,steroids and any antiemetic within 24hr Pt having contraindication or hypersensivity to metocloparamide pregnant female Pt having history of PONV & motion sickness

Design outcomes

Primary

MeasureTime frame
1) To evaluate the efficacy of i.v dexamethasone 5mg + metocloparamide 10mg on PONV 2) To evaluate the efficacy of i.v dexamethasone 2.5mg + metocloparamide 10mg on PONV 3)To evaluate the efficacy of i.v metocloparamide 10mg on PONVTimepoint: at 0-1hr at 1-4 hr at 4-8hr at 8-12hr at 12-24hr

Secondary

MeasureTime frame
comperative evaluation of these drug on POnVTimepoint: at 0-1hr at 1-4 hr at 4-8hr at 8-12hr

Countries

India

Contacts

Public Contactdr onkar singh

subharti medical college,meerut

khoslapp@yahoo.com01212439056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026